Atopic Dermatitis
📧 Sign up to get email alerts when something new happens for Atopic Dermatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-28Clinical Trial Results: A Study to Evaluate Rocatinlimab (AMG 451) in Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD) [Phase 3]
Phase 3 trial evaluating rocatinlimab (AMG 451) in adolescents with moderate-to-severe atopic dermatitis has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2026-08-06Clinical Trial Results: A Study Assessing Rocatinlimab in Combination With Topical Corticosteroid and/or Topical Calcineurin Inhibitors in Adult Participants With Moderate-to-severe Atopic Dermatitis (AD) [Phase 3]
Phase 3 clinical trial evaluating rocatinlimab in combination with topical therapies for adults with moderate-to-severe atopic dermatitis; s…
-
CLINICAL_TRIALS trial_result · 2026-08-05Clinical Trial Results: A 32-week Trial to Evaluate the Efficacy and Safety of Tralokinumab in Subjects With Moderate-to-severe Atopic Hand Eczema Who Are Candidates for Systemic Therapy [Phase 3]
A Phase 3 trial evaluating the efficacy and safety of tralokinumab in moderate-to-severe atopic hand eczema and related atopic dermatitis sh…
-
CLINICAL_TRIALS trial_result · 2026-07-24Clinical Trial Results: A Study to Assess the Safety, Tolerability, and Efficacy of Rocatinlimab in Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD) [Phase 3]
Phase 3 trial results evaluating Rocatinlimab in adolescents with moderate-to-severe atopic dermatitis have been completed with posted resul…
-
CLINICAL_TRIALS trial_result · 2026-07-23Clinical Trial Results: A Study Evaluating Rocatinlimab in Moderate-to-severe Atopic Dermatitis (ROCKET-IGNITE) [Phase 3]
Phase 3 trial results for rocatinlimab in moderate-to-severe atopic dermatitis (ROCKET-IGNITE) have been completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-07-23Clinical Trial Results: A Study Assessing Rocatinlimab on Vaccine Antibody Response in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET - VOYAGER) [Phase 3]
Phase 3 trial evaluating rocatinlimab's effect on vaccine antibody response in adults with moderate-to-severe atopic dermatitis has complete…
-
CLINICAL_TRIALS trial_result · 2026-07-21Clinical Trial Results: BROadband vs Narrowband photoTherapy for Eczema Trial Nested in the CACTI Cohort [NA]
Clinical trial results comparing broadband vs narrowband phototherapy for eczema within the CACTI cohort; study terminated with results post…
-
CLINICAL_TRIALS trial_result · 2026-07-17Clinical Trial Results: Effectiveness and Safety of Lebrikizumab Treatment in Adults and Adolescents With Moderate-to-Severe Atopic Dermatitis [Phase 3]
Phase 3 trial results for lebrolikizumab in adults and adolescents with moderate-to-severe atopic dermatitis show effectiveness and safety d…
-
CLINICAL_TRIALS trial_result · 2026-07-13Clinical Trial Results: Proof of Concept Study of Rilzabrutinib in Adult Patients With Moderate-to-severe Atopic Dermatitis [Phase 2]
Phase 2 proof-of-concept study evaluating rilzabrutinib in adults with moderate-to-severe atopic dermatitis has completed with results poste…
-
CLINICAL_TRIALS trial_result · 2026-06-26Clinical Trial Results: A Study Assessing Rocatinlimab (AMG 451) Monotherapy in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-Horizon) [Phase 3]
Phase 3 study results for rocatinlimab monotherapy in moderate-to-severe atopic dermatitis completed; results posted.
-
CLINICAL_TRIALS trial_result · 2026-06-16Clinical Trial Results: Long-Term Study (AtDvance) to Evaluate GSK1070806 in Atopic Dermatitis. [Phase 2]
Phase 2 long-term study of GSK1070806 in atopic dermatitis has been terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2026-06-04Clinical Trial Results: Longitudinal Endotyping Of Atopic Dermatitis Through Transcriptomic Skin Analysis [Phase 4]
Phase 4 clinical trial results on longitudinal endotyping of atopic dermatitis using transcriptomic skin analysis.
-
CLINICAL_TRIALS trial_result · 2026-06-03Clinical Trial Results: A Dose Finding Study to Investigate the Safety and Effectiveness of GSK1070806 in Adult Participants With Moderate to Severe Atopic Dermatitis [Phase 2]
Phase 2 dose-finding study results for GSK1070806 in adults with moderate to severe atopic dermatitis; study terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: Using Dupilumab to Improve Circadian Function, Sleep and Pruritus in Children With Moderate/Severe Atopic Dermatitis [Phase 4]
Phase 4 trial evaluating dupilumab to improve circadian function, sleep, and pruritus in children with moderate-to-severe atopic dermatitis.
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: A Study Evaluating TRIV-509 in Atopic Dermatitis [Phase 2]
Phase 2 clinical trial update for TRIV-509 in atopic dermatitis.
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Phase 2b Study of EVO756 in Adults With Atopic Dermatitis [Phase 2]
A Phase 2b clinical trial evaluating EVO756 in adults with atopic dermatitis is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: An Open-label, DDI Study to Investigate the Effects of Amlitelimab on the PK of Selected Cytochrome P450 Substrates [Phase 1]
Completed Phase 1 open-label study investigating the effect of amlitelimab on the pharmacokinetics of selected cytochrome P450 substrates to…
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: Open Label, Long-term Study Evaluating Safety and Efficacy of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis [Phase 2]
Phase 2 open-label, long-term study evaluating the safety and efficacy of subcutaneous amlitelimab in adolescents and adults with moderate-t…
-
CLINICAL_TRIALS trial_result · 2026-04-22Clinical Trial Update: Omega-3 Monoglyceride Based Topic Products as Skin Prebiotics for Eczema [NA]
A clinical trial evaluating omega-3 monoglyceride-based topical prebiotics for eczema has been terminated.
-
CLINICAL_TRIALS trial_result · 2026-04-21Clinical Trial Update: A Study to Investigate the Efficacy and Safety of Subcutaneous Lunsekimig (SAR443765) Compared With Placebo in Adult Participants With Moderate-to-severe Atopic Dermatitis [Phase 2]
Phase 2 study evaluating subcutaneous Lunsekimig (SAR443765) vs placebo in adults with moderate-to-severe atopic dermatitis. The trial statu…
-
CLINICAL_TRIALS trial_result · 2026-04-21Clinical Trial Update: A Study of Lebrikizumab Treatment in Adults and Adolescents With Moderate-to-Severe Atopic Dermatitis [Phase 3]
This is a Phase 3 trial update for Lebrikizumab in adults and adolescents with moderate-to-severe atopic dermatitis. The study is currently …
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: Crisaborole vs Fluticasone Propionate in Mild to Moderate Atopic Dermatitis [NA]
A completed randomized trial comparing crisaborole to fluticasone propionate for mild-to-moderate atopic dermatitis (eczema).
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Phase II Clinical Study to Evaluate the Efficacy and Safety of VC005 in Adult Subjects With Mild to Moderate Atopic Dermatitis [Phase 2]
A Phase II clinical study evaluating the efficacy and safety of VC005 in adults with mild to moderate atopic dermatitis has completed.
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: A Phase 3 Study of LNK01001 Capsule in Subjects With Moderate to Severe Atopic Dermatitis. [Phase 3]
A Phase 3 trial evaluating LNK01001 Capsule for adults with moderate-to-severe atopic dermatitis has completed.
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Clinical Study to Evaluate the Safety, Pharmacokinetics and Efficacy of VC005 in Adolescent Subjects With Mild to Moderate Atopic Dermatitis [Phase 1]
A Phase 1 clinical study to evaluate the safety, pharmacokinetics, and efficacy of VC005 in adolescents with mild to moderate atopic dermati…